Sports medicine startup, Biomimedica, raises $14M for synthetic cartilage to repair joints

Biomimedica® Announces the Closing of its Oversubscribed Series B Financing (press release)
 

Biomimedica®, Incorporated (www.biomimedica.com), a medical device start-up company focused on the development and commercialization of its proprietary GRADION™ Total Cartilage Replacement™ (“TCR™”) technology, announced today that it has closed its Series-B financing, raising $11.9 million from a combination of new and existing investors, including conversion of approximately $2.8 million in bridge loans. Participants in this round include new investors Troika Ventures (Russia) and Biedermann M...


Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.